Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors

Author:

Wang Daniel Y.1,Salem Joe-Elie123,Cohen Justine V.4,Chandra Sunandana5,Menzer Christian6,Ye Fei7,Zhao Shilin7,Das Satya1,Beckermann Kathryn E.1,Ha Lisa5,Rathmell W. Kimryn1,Ancell Kristin K.1,Balko Justin M.1,Bowman Caitlin5,Davis Elizabeth J.1,Chism David D.1,Horn Leora1,Long Georgina V.891011,Carlino Matteo S.891213,Lebrun-Vignes Benedicte23,Eroglu Zeynep14,Hassel Jessica C.6,Menzies Alexander M.891213,Sosman Jeffrey A.5,Sullivan Ryan J.4,Moslehi Javid J.1,Johnson Douglas B.1

Affiliation:

1. Vanderbilt Ingram Cancer Center, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee

2. Department of Pharmacology, Pharmacovigilance Unit, AP-HP, Pitié-Salpêtrière Hospital, Paris, France

3. INSERM, UMR ICAN 1166, Sorbonne Universités, UPMC Univ Paris 06, Institute of Cardiometabolism and Nutrition (ICAN), Paris, France

4. Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts

5. Robert H. Lurie Cancer Center, Department of Medicine, Northwestern University Medical Center, Chicago, Illinois

6. National Center for Tumor Diseases, Department of Dermatology, University Hospital Heidelberg, Heidelberg, Germany

7. Vanderbilt Ingram Cancer Center, Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee

8. Melanoma Institute of Australia, Sydney, New South Wales, Australia

9. University of Sydney, Sydney, New South Wales, Australia

10. Royal North Shore Hospital, Sydney, New South Wales, Australia

11. Mater Hospital, Sydney, New South Wales, Australia

12. Department of Medical Oncology, Westmeade Hospital, Sydney, New South Wales, Australia

13. Department of Medical Oncology, Blacktown Hospital, Sydney, New South Wales, Australia

14. Department of Cutaneous Oncology, The Moffitt Cancer Center and Research Institute, Tampa, Florida

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Cited by 1786 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3